CIK 0001237831 · Large accelerated filer
GLOBUS MEDICAL INC
Sign in to watch- Ticker
- GMED
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043744954
- Phone
- 610-930-1800
- Business address
- 2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA, 19403
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,970,014
- in 4 filings, $425K under 10b5-1 plans
Net −$7,970,014. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-25 | Huller Kelly SVP, GC, Corporate Secretary | Sale 10b5-1 | −7,500 | $90.00 | $675K | 0 |
| 2025-11-25 | Huller Kelly SVP, GC, Corporate Secretary | Option exercise · Stock Option (Right to Buy Class A Common Stock) 10b5-1 | −7,500 | 0 | ||
| 2025-11-12 | Davidar David D Director | Option exercise | +25,000 | $25.52 | $638K | 541,275 |
| 2025-11-12 | Davidar David D Director | Sale | −25,000 | $86.00 | $2.2M | 516,275 |
| 2025-11-12 | Davidar David D Director | Option exercise · Stock Option (Right to Buy Class A Common Stock) | −25,000 | 0 | ||
| 2025-11-11 | ZARRILLI STEPHEN T Director | Option exercise | +25,000 | $44.14 | $1.1M | 25,000 |
| 2025-11-11 | ZARRILLI STEPHEN T Director | Sale | −25,000 | $84.29 | $2.1M | 0 |
| 2025-11-11 | ZARRILLI STEPHEN T Director | Option exercise · Stock Option (Right to Buy Class A Common Stock) | −25,000 | 0 | ||
| 2025-11-10 | RHOADS ANN D Director | Sale 10b5-1 | −2,000 | $85.00 | $170K | 15,384 |
| 2025-11-07 | RHOADS ANN D Director | Sale 10b5-1 | −8,000 | $81.00 | $648K | 17,384 |
| 2025-09-15 | RHOADS ANN D Director | Sale 10b5-1 | −10,000 | $58.46 | $585K | 25,384 |
| 2025-07-18 | Pfeil Keith W President, CEO | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +40,000 | 40,000 | ||
| 2025-07-18 | Kline Kyle Senior Vice President, CFO | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +20,909 | 20,909 | ||
| 2025-02-28 | RHOADS ANN D Director | Sale 10b5-1 | −7,500 | $78.68 | $590K | 35,384 |
| 2025-01-23 | Davidar David D Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2025-01-23 | DeFord John A Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2025-01-23 | Douglas Robert Andrew Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2025-01-23 | Huller Kelly SVP, GC, Corporate Secretary | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +40,000 | 40,000 | ||
| 2025-01-23 | Lemaitre Dan Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2025-01-23 | Norwalk Leslie V Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 |
Page 4 of 10 · 200 trades